112 related articles for article (PubMed ID: 4008638)
1. Complement-dependent toxicity of serum from myasthenic patients to muscle cells in culture.
Childs LA; Harrison R; Lunt GG
J Neuroimmunol; 1985 Jul; 9(1-2):69-80. PubMed ID: 4008638
[TBL] [Abstract][Full Text] [Related]
2. Complement-dependent lysis of cultured rat myotubes by myasthenic immunoglobulins.
Ashizawa T; Appel SH
Neurology; 1985 Dec; 35(12):1748-53. PubMed ID: 4069366
[TBL] [Abstract][Full Text] [Related]
3. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
Tzartos SJ; Sophianos D; Zimmerman K; Starzinski-Powitz A
J Immunol; 1986 May; 136(9):3231-8. PubMed ID: 3958494
[TBL] [Abstract][Full Text] [Related]
4. Effect of myasthenic patient sera on the number and distribution of acetylcholine receptors in muscle and nerve-muscle cultures from rat. Correlations with clinical state.
Eymard B; de la Porte S; Pannier C; Berrih-Aknin S; Morel E; Fardeau M; Bach JF; Koenig J
J Neurol Sci; 1988 Aug; 86(1):41-59. PubMed ID: 3171596
[TBL] [Abstract][Full Text] [Related]
5. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
6. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
[TBL] [Abstract][Full Text] [Related]
8. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera.
Sophianos D; Tzartos SJ
J Autoimmun; 1989 Dec; 2(6):777-89. PubMed ID: 2619869
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
[TBL] [Abstract][Full Text] [Related]
10. Interaction of foetal and adult human acetylcholine receptors with serum from patients with myasthenia gravis.
Lotwick H; Harrison R; Lunt G; Behan P
J Neuroimmunol; 1983 Jun; 4(3):167-74. PubMed ID: 6853696
[TBL] [Abstract][Full Text] [Related]
11. Antibody-induced degradation of acetylcholine receptor in myasthenia gravis: clinical correlates and pathogenetic significance.
Tronconi BC; Brigonzi A; Fumagalli G; Sher M; Cosi V; Piccolo G; Clementi F
Neurology; 1981 Nov; 31(11):1440-4. PubMed ID: 7198191
[TBL] [Abstract][Full Text] [Related]
12. Complement-mediated muscle damage produced by myasthenic sera.
Childs LA; Harrison R; Lunt GG
Ann N Y Acad Sci; 1987; 505():180-93. PubMed ID: 3479926
[No Abstract] [Full Text] [Related]
13. An electrophysiological study of the effects of myasthenia gravis sera and complement on rat isolated muscle fibres.
Mozrzymas JW; Lorenzon P; Riviera AP; Tedesco F; Ruzzier F
J Neuroimmunol; 1993 Jun; 45(1-2):155-62. PubMed ID: 8331159
[TBL] [Abstract][Full Text] [Related]
14. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
15. Improved radioassay of anti-acetylcholine receptor antibody: application for the detection of extremely low antibody titers in sera from patients with myasthenia gravis.
Ohta M; Ohta K; Mori F; Itoh N; Nishitani H; Hayashi K
Clin Chem; 1990 Jun; 36(6):911-3. PubMed ID: 2357833
[TBL] [Abstract][Full Text] [Related]
16. Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
Kaplan I; Blakely BT; Pavlath GK; Travis M; Blau HM
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8100-4. PubMed ID: 2236023
[TBL] [Abstract][Full Text] [Related]
17. Myasthenic patients' IgG causes redistribution of acetylcholine receptors: freeze-fracture studies.
Pumplin DW; Drachman DB
J Neurosci; 1983 Mar; 3(3):576-84. PubMed ID: 6827310
[TBL] [Abstract][Full Text] [Related]
18. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
19. A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in 'antibody-negative' myasthenia gravis.
Brooks EB; Pachner AR; Drachman DB; Kantor FS
J Neuroimmunol; 1990 Jun; 28(1):83-93. PubMed ID: 2341562
[TBL] [Abstract][Full Text] [Related]
20. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
